Immunotherapy-Transfer Factor in Coccidioidomycosis

  • David A. Stevens
Part of the Current Topics in Infectious Disease book series (CTID)


Since, as indicated in Chapter 5, defective immunity, notably cell-mediated immunity, is closely associated with progressive coccidioidomycosis, attempts to treat the disease by altering the host response are eminently logical. In coccidioidomycosis, almost all the clinical experience with this approach has been by the use of transfer factor. Conversely, probably no disease has provided more rationale for further clinical study of transfer factor.


Migration Inhibition Factor Transfer Factor Related Antigen Lepromatous Leprosy Chronic Mucocutaneous Moniliasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H. S. Lawrence and F. T. Valentine, Transfer factor and other mediators of cellular immunity, Am. J. Pathol. 60: 437–450 (1970).PubMedGoogle Scholar
  2. 2.
    H. S. Lawrence, Transfer factor, Adv. Immunol. 11:195–266 (1969).Google Scholar
  3. 3.
    F. M. Burnet, Transfer factor—a theoretical discussion, J. Allergy Clin. Immunol. 54: 1–13 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    C. H. Kirkpatrick, Properties and activities of transfer factor, J. Allergy Clin. Immunol. 55: 411–421 (1975).PubMedCrossRefGoogle Scholar
  5. 5.
    F. T. Rapaport, H. S. Lawrence, J. W. Millar, D. Pappagianis, and C. E. Smith, Transfer of delayed hypersensitivity to coccidioidin in man, J. Immunol. 84: 358–367 (1960).PubMedGoogle Scholar
  6. 6.
    L. Cohen, R. S. Holzman, F. T. Valentine, and H. S. Lawrence, Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates, J. Exp. Med. 143: 791–804 (1976).PubMedCrossRefGoogle Scholar
  7. 7.
    E. A. Peterson, J. A. Frey, M. Dinowitz, and D. Rifkind, Transfer of delayed hypersensitivity to mice with human immune cell extracts, in: Transfer Factor—Basic Properties and Clinical Applications ( M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick, eds.), Academic Press, New York (1976), pp. 387–398.Google Scholar
  8. 8.
    D. Rifkind, J. A. Frey, E. A. Peterson, and M. Dinowitz, Transfer of delayed-type hypersensitivity in mice to microbial antigens with dialyzable transfer factor, Infect. Immun. 16: 258–262 (1977).PubMedGoogle Scholar
  9. 9.
    D. Rifkind, J. A. Frey, and M. Dinowitz, Susceptibility of murine transfer factor to dimerized ribonuclease A, Infect. Immun. 16: 920–922 (1977).PubMedGoogle Scholar
  10. 10.
    R. E. Rocklin, R. A. Chilgren, R. Hong, and J. R. David, Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro, Cell. Immunol. 1: 290–299 (1970).PubMedCrossRefGoogle Scholar
  11. 11.
    C. H. Kirkpatrick, J. W. Chandler, and R. N. Schimke, Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity, Clin. Exp. Immunol. 6: 375–385 (1970).PubMedGoogle Scholar
  12. 12.
    J. R. Graybill, J. Silva, R. H. Alford, and D. E. Thor, Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor, Cell Immunol. 8: 120–135 (1973).PubMedCrossRefGoogle Scholar
  13. 13.
    D. A. Stevens, D. Pappagianis, V. A. Marinkovich, and T. F. Waddell, Immunotherapy in recurrent coccidioidomycosis, Cell Immunol. 12: 37–48 (1974).PubMedCrossRefGoogle Scholar
  14. 14.
    A. Catanzaro, L. Spitler, and K. M. Moser, Immunotherapy of coccidioidomycosis, J. Clin. Invest. 54: 690–701 (1974).PubMedCrossRefGoogle Scholar
  15. 15.
    P. Cloninger, L. D. Thrupp, G. A. Granger, and H. S. Novey, Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis, West. J. Med. 120: 322–325 (1974).PubMedGoogle Scholar
  16. 16.
    A. Catanzaro, L. Spitler . (Coccidioidomycosis Cooperative Treatment Group), Clinical and immunologic results of transfer factor therapy in coccidioidomycosis, in: Transfer Factor—Basic Properties and Clinical Applications ( M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick, eds.), Academic Press, New York (1976), pp. 477–494.Google Scholar
  17. 17.
    J. R. Graybill . (Coccidioidomycosis Cooperative Treatment Group), The clinical couse of coccidioidomycosis following transfer factor therapy, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami, Fla. (1977), pp. 335–345.Google Scholar
  18. 18.
    D. A. Stevens . (Coccidioidomycosis Cooperative Treatment Group), Transfer factor therapy of infectious diseases, in: Recent Advances in Dermatopharmacology ( P. Frost, E. C. Gomez, and N. Zaias, eds.), Spectrum, Holliswood, N.Y. (1977), pp. 67–74.Google Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • David A. Stevens

There are no affiliations available

Personalised recommendations